Medipost

About Medipost

Medipost is a biotechnology company in Korea specializing in stem cell therapies, stem cell banking, and related life science products. The company develops and manufactures first- and second-generation stem cell therapeutics, including CARTISTEM and PNEUMOSTEM, and operates CDMO services with GMP facilities, aiming at global markets. It emphasizes research and development, regulatory compliance, and partnership through its R&D institutes, GMP centers, and global CDMO capabilities. Headquartered in Seongnam, Gyeonggi Province, Medipost positions itself as a leader in regenerative medicine and stem cell technologies.